Baixinan (2185.HK): Medtronic RDN products have been approved in the US and it is expected that the domestic commercialization process will soon begin
Baishinan (2185.HK), a domestic RDN pioneer, is expected to be approved for release in 24
Baixinan-B (2185.HK): IPO Purchase Guide
No Data